Showing results (3281-3290 of 3,354) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|February 8, 1992
Selection of items and avoidance of bias in quality of life scalesM E HylandPharmacoeconomics|October 4, 1996
A practical guide for calculating indirect costs of diseaseM A Koopmanschap, F F RuttenPharmacoeconomics|October 4, 1996
German health economic cost evaluation on oral ganciclovir in treating cytomegalovirus retinitisJ M Graf von den Schulenburg, S Wähling, M StollPharmacoeconomics|March 8, 1998
The use of QALY and non-QALY measures of health-related quality of life. Assessing the state of the artM Deverill, J Brazier, C Green, et al.Pharmacoeconomics|September 30, 2000
Economic evaluation of enoxaparin sodium versus heparin in unstable angina. A French sub-study of the ESSENCE trialB Detournay, X Huet, F Fagnani, et al.Pharmacoeconomics|January 5, 2002
Accounting for noncompliance in pharmacoeconomic evaluationsD A Hughes, A Bagust, A Haycox, et al.Pharmacoeconomics|February 26, 2003
Cost comparisons of pharmacological strategies in open-heart surgeryPrabashni Reddy, Jessica SongPharmacoeconomics|July 3, 2002
Standardisation of costs: the Dutch Manual for Costing in economic evaluationsJan B Oostenbrink, Marc A Koopmanschap, Frans F H RuttenPharmacoeconomics|April 17, 2001
Cost effectiveness of emedastine versus levocabastine in the treatment of allergic conjunctivitis in 7 European countriesC G Pinto, A Lafuma, F Fagnani, et al.Pageof 336